JP2013515019A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515019A5 JP2013515019A5 JP2012545091A JP2012545091A JP2013515019A5 JP 2013515019 A5 JP2013515019 A5 JP 2013515019A5 JP 2012545091 A JP2012545091 A JP 2012545091A JP 2012545091 A JP2012545091 A JP 2012545091A JP 2013515019 A5 JP2013515019 A5 JP 2013515019A5
- Authority
- JP
- Japan
- Prior art keywords
- poloxamer
- polysorbate
- suspension
- surfactant
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPCT/DK2009/000267 | 2009-12-22 | ||
| DK2009000267 | 2009-12-22 | ||
| US29309110P | 2010-01-07 | 2010-01-07 | |
| US61/293,091 | 2010-01-07 | ||
| PCT/DK2010/000183 WO2011076208A2 (en) | 2009-12-22 | 2010-12-22 | Calcipotriol monohydrate nanocrystals |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515019A JP2013515019A (ja) | 2013-05-02 |
| JP2013515019A5 true JP2013515019A5 (https=) | 2013-12-26 |
| JP5816194B2 JP5816194B2 (ja) | 2015-11-18 |
Family
ID=43618145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012545091A Active JP5816194B2 (ja) | 2009-12-22 | 2010-12-22 | カルシポトリオール一水和物ナノクリスタル |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20130039952A1 (https=) |
| EP (1) | EP2515874B1 (https=) |
| JP (1) | JP5816194B2 (https=) |
| CN (1) | CN102770125B (https=) |
| AU (1) | AU2010335655B2 (https=) |
| BR (1) | BR112012015449B1 (https=) |
| CA (1) | CA2785253A1 (https=) |
| ES (1) | ES2523119T3 (https=) |
| IL (1) | IL220516A (https=) |
| MX (1) | MX2012007234A (https=) |
| NZ (1) | NZ601000A (https=) |
| PL (1) | PL2515874T3 (https=) |
| RU (1) | RU2555339C2 (https=) |
| WO (1) | WO2011076208A2 (https=) |
| ZA (1) | ZA201204618B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX375448B (es) * | 2013-07-18 | 2025-03-06 | Mannkind Corp | Composiciones farmacéuticas en polvo seco estables al calor y métodos. |
| CN105534996B (zh) * | 2016-02-24 | 2018-05-01 | 长沙佰顺生物科技有限公司 | 一种治疗银屑病的药物组合物 |
| CA3029244A1 (en) | 2016-07-05 | 2018-01-11 | Kratos LLC | Passivated pre-lithiated micron and sub-micron group iva particles and methods of preparation thereof |
| WO2018183909A1 (en) * | 2017-03-31 | 2018-10-04 | Kratos LLC | Precharged negative electrode material for secondary battery |
| CN108904445A (zh) * | 2018-08-06 | 2018-11-30 | 江苏知原药业有限公司 | 钙泊三醇纳米悬浮液 |
| CN109157661B (zh) * | 2018-09-10 | 2021-09-24 | 南京工业大学 | 一种配体辅助下用氧化物silica包覆疏水性分子晶体的方法 |
| RU2749360C1 (ru) * | 2020-10-09 | 2021-06-09 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) | Способ лечения ладонно-подошвенного пустулеза |
| JP7751298B2 (ja) * | 2021-07-14 | 2025-10-08 | 株式会社ツツミプランニング | 浸透深さの調整方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8315787D0 (en) * | 1983-06-08 | 1983-07-13 | Briggs J H | Coolant spray |
| US4758432A (en) * | 1984-10-15 | 1988-07-19 | Richardson-Vicks Inc. | Topical treatment of skin inflammatory disorders |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| GB9300763D0 (en) * | 1993-01-15 | 1993-03-03 | Leo Pharm Prod Ltd | Chemical compound |
| DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
| GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
| US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
| DE19932157A1 (de) | 1999-07-13 | 2001-01-18 | Pharmasol Gmbh | Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln |
| US6403654B1 (en) * | 2000-04-13 | 2002-06-11 | Mariana De Oliveira | Compositions for and method of treatment for psoriasis |
| BRPI0114927B8 (pt) * | 2000-10-27 | 2021-05-25 | Leo Pharma As | composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição |
| US6814319B2 (en) * | 2000-12-06 | 2004-11-09 | Pharmacia & Upjohn Company | Laboratory scale milling process |
| FR2834212B1 (fr) * | 2001-12-27 | 2004-07-09 | Besins Int Belgique | Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques |
| ATE411010T1 (de) | 2002-12-13 | 2008-10-15 | Jagotec Ag | Topische nanopartikel-spironolacton-formulierung |
| DK1658263T3 (da) | 2003-07-24 | 2010-09-27 | Leo Pharma As | Aminobenzophenonforbindelser |
| WO2005107710A2 (en) * | 2004-05-06 | 2005-11-17 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
| US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
| KR101260236B1 (ko) | 2004-12-13 | 2013-05-06 | 레오 파마 에이/에스 | 트리아졸 치환된 아미노벤조페논 화합물 |
| WO2006129161A2 (en) * | 2005-06-01 | 2006-12-07 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
| EP1948130B1 (en) * | 2005-10-24 | 2013-09-11 | Precision Dermatology, Inc. | Topical pharmaceutical foam composition |
| DK2054042T3 (da) * | 2006-06-30 | 2020-08-03 | Iceutica Pty Ltd | Fremgangsmåder til fremstilling af biologisk aktive forbindelser i nanopartikelform |
| WO2008058755A1 (en) * | 2006-11-17 | 2008-05-22 | Abbott Gmbh & Co. Kg | Nanocrystals for use in topical cosmetic formulations and method of production thereof |
| EP2125736B1 (en) | 2006-12-22 | 2011-03-30 | Leo Pharma A/S | Substituted acetophenones useful as pde4 inhibitors |
| CA2676933C (en) | 2007-02-28 | 2015-09-29 | Leo Pharma A/S | Novel phosphodiesterase inhibitors |
| JP2010524864A (ja) | 2007-04-19 | 2010-07-22 | レオ ファーマ アクティーゼルスカブ | Ｓｒｃファミリーキナーゼ阻害剤 |
| CA2685516A1 (en) | 2007-05-11 | 2008-11-20 | Sonneborn Inc. | Petrolatums having silicone-like properties |
| RU2544011C2 (ru) | 2008-12-19 | 2015-03-10 | Лео Фарма А/С | Триазолопиридины в качестве ингибиторов фосфодиэстеразы для лечения кожных заболеваний |
-
2010
- 2010-12-22 MX MX2012007234A patent/MX2012007234A/es active IP Right Grant
- 2010-12-22 NZ NZ601000A patent/NZ601000A/en unknown
- 2010-12-22 BR BR112012015449-4A patent/BR112012015449B1/pt active IP Right Grant
- 2010-12-22 JP JP2012545091A patent/JP5816194B2/ja active Active
- 2010-12-22 CN CN201080064526.6A patent/CN102770125B/zh active Active
- 2010-12-22 EP EP10803440.6A patent/EP2515874B1/en active Active
- 2010-12-22 AU AU2010335655A patent/AU2010335655B2/en active Active
- 2010-12-22 RU RU2012130412/15A patent/RU2555339C2/ru active
- 2010-12-22 CA CA2785253A patent/CA2785253A1/en not_active Abandoned
- 2010-12-22 ES ES10803440.6T patent/ES2523119T3/es active Active
- 2010-12-22 PL PL10803440T patent/PL2515874T3/pl unknown
- 2010-12-22 US US13/518,214 patent/US20130039952A1/en not_active Abandoned
- 2010-12-22 WO PCT/DK2010/000183 patent/WO2011076208A2/en not_active Ceased
-
2012
- 2012-06-19 IL IL220516A patent/IL220516A/en active IP Right Grant
- 2012-06-21 ZA ZA2012/04618A patent/ZA201204618B/en unknown
-
2014
- 2014-03-20 US US14/220,843 patent/US20140322331A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515019A5 (https=) | ||
| WO2012177886A3 (en) | Process of forming crystals for use in a personal care composition | |
| EP3495446A3 (en) | Particles containing one or more controlled release cross-linked active agents | |
| MX2023004255A (es) | Comprimidos que comprenden 2-hidroxi-6-((2-(1-isopropil-1h-pirazol -5-il)piridin-3-il)metoxi)benzaldehido. | |
| NZ742004A (en) | Pharmaceutical nanoparticles showing improved mucosal transport | |
| AR067747A1 (es) | Metodos para producir suspension de aripiprazol y formulacion liofilizada | |
| AR093764A1 (es) | Composiciones de limpieza que comprenden particulas estructuradas | |
| WO2011063990A8 (en) | Spider silk particles for controlled and sustained delivery of compounds | |
| JP2010514660A5 (https=) | ||
| WO2011106075A3 (en) | A microelectronic structure including a low k dielectric and a method of controlling carbon distribution in the structure | |
| MX2018011190A (es) | Cuerpo de dispersion de particulas finas de material de proteccion de infrarrojo cercano, cuerpo de proteccion de infrarrojo cercano y estructura laminada de proteccion de infrarrojo cercano y metodo de produccion de los mismos. | |
| CN102488920B (zh) | 核壳结构的α-半水硫酸钙/羟基磷灰石复合颗粒及制备 | |
| BR112018009644A2 (pt) | micropartículas agregantes sólidas modificadas na superfície, material injetável, processo para preparação de micropartículas agregantes sólidas modificadas na superfície, método para tratamento de um distúrbio ocular, e, uso de micropartículas agregantes sólidas modificadas na superfície | |
| WO2013132457A3 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
| WO2010015298A3 (de) | Kristalline wirkstoff-mikropartikel, verfahren zu deren herstellung und verwendung in arzneimitteln | |
| WO2017177004A8 (en) | Tertiary amides and method of use | |
| NZ601000A (en) | Calcipotriol monohydrate nanocrystals | |
| Yu et al. | Porous Al2O3 microspheres prepared by a novel ice-templated spray drying technique | |
| WO2010102923A3 (en) | Riluzole aqueous suspensions | |
| Ogino et al. | Preheating temperature and growth temperature dependence of InP nanowires grown by self-catalytic VLS mode on InP substrate | |
| Dong et al. | Clay as a matrix former for spray drying of drug nanosuspensions | |
| HK1214951A1 (zh) | 眼用製劑 | |
| MX359554B (es) | Microesferas cristalinas y proceso para fabricacion de las mismas. | |
| WO2013025442A3 (en) | Concentrated felbamate formulations for parenteral administration | |
| MY169360A (en) | Stable nanoparticulate suspension and method for production |